DAILYPEPTIDE GUIDE
Supplier analysis

AminoVault

aminovault.com

Confidence BoperatingReviewed 2026-08-25
RSES v1.07.1/ 10

RSES scope. RSES evaluates publicly available research-supplier documentation. It does not guarantee product identity, safety, sterility, future-lot consistency, regulatory compliance, or suitability for human use. Research-use-only labeling is not a safety finding.

RSES interpretationconditional qualification
Category ratings

Documentation evidence profile

Analytical evidence4.3 / 5 · 28%
Lot traceability and sampling4.2 / 5 · 18%
Laboratory and method credibility4.0 / 5 · 14%
Contamination controls2.8 / 5 · 12%
Cross-lot consistency3.5 / 5 · 8%
Corporate transparency3.0 / 5 · 7%
Catalog accuracy2.2 / 5 · 5%
Corrective-action record1.5 / 5 · 4%
Community signal1.5 / 5 · 4%
Evidence sources

Documentation reviewed

[Vendor document]

Vendor documentation

Evidence class: Vendor document. Public lab-results page exposes lot-specific ILS and MDx certificates; Site claims domestic production, dual testing, >=99% purity and eight analytical checks

Source URL unavailable in the dataset
[Third-party document review]

Independent documentation review

Evidence class: Third-party document review. Peptigrity independently resolved MDx COA 29151; PeptideTrust reviewed public batch-specific MDx reports; Independent review coverage remains mostly vendor-selected rather than blind retail sampling

Source URL unavailable in the dataset